Alector moved into MBC BioLabs on the day we opened our doors, and now just over five years later they have two programs in the clinic, a partnership with AbbVie, and are now are preparing to g [...]
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cypre and Molecular Devices signed a co-marketing agreement to jointly market Cypre’s Symphony®/VersaGel® 3D cel [...]
Nitrome Biosciences and SyntheX are the recipients of the MBC 2018 Golden Ticket program sponsored by Celgene Corporation.
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS TIMES By Ron Leuty – Reporter, San Francisco Business Times Jan 7, 2019, 5:18pm EST Read original online a [...]
January 10, 2019 2:30 - 4:30pm Beyond Next Ventures and MBC BioLabs invite you to explore the latest in Japanese life science innovation on January 10th, when seven startups specially selected for t [...]
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing.The partners [...]
Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, CEO of Mammoth Biosciences, who was featured on Forbes 2019 Healthcare 30 Under 30. Trevor is a 29-year-old S [...]
November 16, 2018 3:30 - 5pm After closing a $35 million Series B, ViewPoint Therapeutics will be moving to their own lab space in South San Francisco. They were one of the very first companies to m [...]